Clinical trial
The Efficacy and Safety of Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection
NCT04296695 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 14, 2021
- Completion date
- June 6, 2025
- Enrollment
- 202 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1-infection